Pharmagupshup,pharmacy,free gpat material,niper,free niper material, pharma vacancy, pharma jobs, pharmacy seminar,pharma conference,pharma awards,pharma books,pharma study material,pharma services, pharma news,pharma colleges,pharma acts,sops

Wednesday, April 11, 2012

'SMART MOVE WITH IMMEDIATE EFFECT' By Daxesh Patel .Pharmagupshup Starts 'Article Make and send to Pharmagupshup'


Story starts when Hyderabad based Natco Pharma applied for compulsory licence for the drug NEXAVAR (sorafenib tosylate) of Bayer which is Germany based company.Natco filed for compulsory licence under section 84 of Indian patent act, 1970. 
The order was issued by India Patents Office as a 'Compulsory Licence' under the Indian Patent Act, which is in compliance with the TRIPS agreement of the World Trade Organization with two justifications.

  1. First that after granting of patent in 2008 company only imported small amount of drug to market in India.
  2. second price of essential medicine should be affordable. (in case of Nexavar its price is about 2.8lacs for 120 tablets ).
    Now natco will sell it at price of Rs.8,880 for 120 tablet which will be good for cancer patient and  Nexavar is basically is an oral multiple kinase inhibitor for the treatment of patients with unresectable hepatocellular carcinoma (HCC).
    Taking that move in consideration Roche Pharmaceutical made agreement with Emcure pharmaceutical for its two drugs to produce its biologic drugs Herceptinand MabThera for India and other developing markets.For Roche it is good to have large chunk of profit coming from sales of these biologics which will come from Emcure Pharma rather than 7-9% royalty (as said to be given to Bayer Pharma in above case).

"This deal with Emcure is a smart move by Roche, with this it can deter the entry of other generic companies, and also offer affordable drugs for a country like India," said Anjan Sen, director, life sciences and healthcare, Deloitte India.

Pharmagupshup Want to Start New Service 'Articles'.We want  that Our Indian Pharmacy Students will get All Topic related Information  or Article of pharmacy from our is not easy task.but we start at initial Make Article (PDF file ) or PowerPoint (PPT)  & send us.we will publish  your file on Pharmagupshup with your name and Photo.

Email ID:


1) File Should Be in proper manner.

2)We allow that you can make article from different source.we allow copy paste information but information should be in a such a manner that reader can easily understand and proper manner.

File Format

The preferred format of all File is MS Word. Illustrations (figures) and images must be inserted in the manuscript at the position they should appear when published.

Preparation of File

Mode of Presenting Paper is English. Each file should be typed single-spaced on A4 (8.5" × 11") paper size with 1 inch margins. It should be arranged in the following order: Title, Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgement and References.


So Make Article and Send Us.....



Post a Comment

Copyright © Pharmagupshup | Powered by Pharmagupshup Hitesh Katariya